Showing results (2081-2090 of 10,388) with videos related to

Sort By:
Pageof 1,039
Vaccines|February 24, 2024
A Practical Guide to Full Value of Vaccine AssessmentsCaroline Trotter, Birgitte Giersing, Ann Lindstrand, et al.
Vaccines|February 24, 2024
Human Tick-Borne Diseases and Advances in Anti-Tick Vaccine Approaches: A Comprehensive ReviewMarie-Edith Nepveu-Traversy, Hugues Fausther-Bovendo, George Giorgi Babuadze
Vaccines|February 24, 2024
Assessing the Implementation Determinants of Pilot Malaria Vaccination Programs in Ghana, Kenya, and Malawi through a Complexity Lens: A Rapid Review Using a Consolidated Framework for Implementation ResearchAbdu A Adamu, Rabiu I Jalo, Duduzile Ndwandwe, et al.
Vaccines|February 24, 2024
Bacterial Vaccinations in Patients with Chronic Obstructive Pulmonary DiseaseDóra Paróczai, Katalin Burian, Andras Bikov
Vaccines|February 24, 2024
Measuring Zero-Dose Children: Reflections on Age Cohort Flexibilities for Targeted Immunization Surveys at the Local LevelGustavo C Corrêa, Md Jasim Uddin, Tasnuva Wahed, et al.
Vaccines|February 24, 2024
Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome ParametersEmmanouil Karampinis, Myrto-Maria Papadopoulou, Kleoniki Chaidaki, et al.
Vaccines|February 24, 2024
Human Papillomavirus Vaccination in Pediatric, Adolescent, and Young Adult Cancer Survivors-Opportunity to Address Gaps in Cancer Prevention and SurvivorshipMelissa A Kluczynski, Elisa M Rodriguez, Cailey S McGillicuddy, et al.
Vaccines|February 24, 2024
Status of Routine Immunization Coverage in the World Health Organization African Region Three Years into the COVID-19 PandemicFranck Mboussou, Sarah Kada, Maria Carolina Danovaro-Holliday, et al.
Vaccines|February 24, 2024
Optimization and Validation of a Harmonized Protocol for Generating Therapeutic-Grade Dendritic Cells in a Randomized Phase II Clinical Trial, Using Two Varied Antigenic SourcesAbirami Seetharaman, Vasanth Christopher, Hemavathi Dhandapani, et al.
Vaccines|February 24, 2024
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-UpZafer Sezer, Shaikh Terkis Islam Pavel, Ahmet Inal, et al.
Pageof 1,039